2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Covid and Its Impact on Cancer
The first half of 2020 saw the advent of coronavirus disease 2019 (COVID-19) as a pandemic, which had an immediate and significant impact on cancer care. The COVID-19 pandemic has had a wide-ranging detrimental effect on cancer care, with variable degrees of severity in different places throughout the world. Patients with cancer are a vulnerable population, and they are exposed to a variety of problems during pandemics, including infection susceptibility and disruption of their cancer or regular medical care. Potential cardiovascular complications in cancer patients who have also been infected with SARS-CoV-2 are one of the most pressing concerns for clinicians. The renin-angiotensin-aldosterone system (RAAS) is another area of concern in COVID-19 positive cancer patients.
- RAAS
- Cardiovascular complications
- Key biomarkers in COVID-19 cancer patients
- Oncology Consultation and Care During and Post-COVID-19
Rajvir Dahiya
University of California San Francisco, United States
Michael Thompson
University of Toronto, Canada
Patricia Tai
University of Saskatchewan, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Ratan Kumar Sarkar
Independent Researcher, India
Mudalsha Ravina
All India Institute of Medical Sciences, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India